Prestige Biologics Co., Ltd. (KOSDAQ: 334970)
South Korea
· Delayed Price · Currency is KRW 5,570.00
-130.00 (-2.28%)
Nov 18, 2024, 1:01 PM KST
Prestige Biologics Revenue
In the fiscal year ending June 30, 2024, Prestige Biologics had annual revenue of 2.17B KRW with 24.24% growth. Prestige Biologics had revenue of -135.06M in the quarter ending June 30, 2024, a decrease of -352.16%.
Revenue
2.17B
Revenue Growth
-23.46%
P/S Ratio
158.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
434.31B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition